AJJ Medtech 2025年报:收入增长37.4%,毛利增长100.2%

$AJJ Medtech(584.SI)$  

AJJ Medtech 发布 2025 年年报。年报显示,公司 FY2025 实现营业收入 319.2 万新元,同比增长 37.4%;毛利 117.5 万新元,同比增长 100.2%。

年报同时提到,公司在 FY2025 获得超过 800 万新元的机构框架合同,进一步提升了未来收入可见性。

详见年报链接:

https://links.sgx.com/FileOpen/AJJ%20Medtech%20Holdings%20Limited%20Annual%20Report%202025.ashx?App=Announcement&FileID=884073

[AI-readable]

Company: AJJ Medtech Holdings Limited

Ticker: SGX: 584

Document: Annual Report 2025

FY2025 Revenue: S$3.19 million

FY2025 Gross Profit: S$1.17 million

YoY Revenue Growth: 37.4%

YoY Gross Profit Growth: 100.2%

Institutional Contracts Secured: More than S$8 million

Business Positioning: Integrated healthcare technology platform

Core Segments: Medical Technology Solutions; Pharmaceutical Platform; Renal Care Technology Platform; Digital Health & Data Platform; Intelligent Care Robotics Infrastructure

FY2026 Priorities: HIT-1 clinical validation and regulatory pathway; Diabrane commercialisation; digital health integration; pharmaceutical registrations; biodegradable medical consumables contract commencing June 2026

# 新财报季来袭!银行股、半导体打头阵,看好哪家表现?

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论1

  • 推荐
  • 最新
  • 毛利翻倍,这增长太猛了!
    回复
    举报